Researched applications In the published preclinical and clinical literature the effects of Cagrilintide are documented in the following areas: Obesity (stand-alone) , Phase 2 data (Lau 2021, 10.8 % at 4.5 mg) Obesity + Semaglutide (CagriSema) , Phase 3 REDEFINE 1 (25.3 %) T2DM + obesity , Phase 3 REDEFINE 2 Cardiovascular prevention , Phase 3 REDEFINE 3 (n ~ 7000) MASLD/MASH , exploratory in Phase 2 Type 2 diabetes (monotherapy) , preclinical data Prediabetes , exploratory plans Science & studies 4.1 Key publications Lau D.C.W., Erichsen L., Francisco A.M., et al
To KK, Chua GT, Kwok KL, et al
Siskind, D., Wysoczanski, D., Russell, A
It offers a solid boost to the immune function, offering protection from infections
For example, if you normally inject on Monday but need flexibility, you could move your injection day to Tuesday or Wednesday for that week only, then resume your original Monday schedule the following week
While not a scientific publication, Morgan Stanley recently surveyed 300 GLP-1 users and found that alcohol consumption and cigarette smoking had dropped substantially